Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | HLA-A2 restricted synthetic peptide vaccine + Imiquimod |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| HLA-A2 restricted synthetic peptide vaccine | HLA-A2 restricted synthetic tumor antigen | HLA-A2 restricted synthetic peptide vaccine is a cancer vaccine comprised of synthetic peptides for tumor associated antigens, which may induce increased anti-tumor immune response (PMID: 23955319). | ||
| Imiquimod | Aldara | Imiquimod acetate |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01795313 | Phase 0 | HLA-A2 restricted synthetic peptide vaccine + Imiquimod | Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides with Imiquimod | Recruiting | USA | 0 |